Malignant Pleural Mesothelioma

被引：0
作者：
Siva Raja
Sudish C. Murthy
David P. Mason
机构：
[1] Cleveland Clinic Foundation,Department of Cardiothoracic Surgery
来源：
Current Oncology Reports | 2011年 / 13卷
关键词：
Mesothelioma; Multimodality therapy; Extrapleural pneumonectomy; Pleurectomy; Malignant pleural mesothelioma; Lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000–3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease. In the past, the treatment of this disease was limited to marginally effective chemotherapy and morbid surgery. This review explores the clinical presentation of MPM, its diagnostic approach and the relevant and recent studies that define the role of chemotherapy, radiation, and various surgical options. Currently, even with aggressive surgical interventions and multimodality strategies, cure remains elusive, although life prolongation has been achieved. Additionally, promising new therapies and interventions that are currently being studied are introduced in this review.
引用
收藏
页码：259 / 264
页数：5
相关论文
共 112 条
[21]  
Akhurst T(2001)Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma Lung Cancer 34 279-287
[22]  
Gonen M(2008)Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma Int J Surg 6 293-297
[23]  
Larson SM(2009)A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma J Thorac Cardiovasc Surg 137 453-458
[24]  
Rusch VW(2009)Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study J Thorac Cardiovasc Surg 138 405-411
[25]  
Schouwink JH(2006)Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma J Clin Oncol 24 1561-1567
[26]  
Kool LS(1994)A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 1156-1163
[27]  
Rutgers EJ(1995)Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience J Surg Oncol 60 262-267
[28]  
Erasmus JJ(2003)Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma Ann Surg Oncol 10 176-182
[29]  
Truong MT(2010)Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer Expert Opin Pharmacother 11 2363-2389
[30]  
Smythe WR(2005)Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B Clin Cancer Res 11 2300-2304
12345678910